Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?
暂无分享,去创建一个
Donna Rowen | Julie Ratcliffe | Oliver Rivero-Arias | Nancy Devlin | J. Ratcliffe | N. Devlin | O. Rivero-Arias | D. Rowen
[1] Wendy J. Ungar,et al. Economic Evaluation in Child Health , 2010 .
[2] Mandy Ryan,et al. For better or worse? Investigating the validity of best–worst discrete choice experiments in health , 2019, Health economics.
[3] Jason Madan,et al. A Systematic Review and Meta-analysis of Childhood Health Utilities , 2017, Medical decision making : an international journal of the Society for Medical Decision Making.
[4] H. Raat,et al. Parent-reported health outcomes in infants/toddlers: measurement properties and clinical validity of the ITQOL-SF47 , 2013, Quality of Life Research.
[5] I. Kaitila,et al. Quality of life in early adolescence: A sixteendimensional health-related measure (16D) , 1996, Quality of Life Research.
[6] J. Brazier,et al. The development of a preference‐based measure of health in children with atopic dermatitis , 2005, The British journal of dermatology.
[7] M. Cowie. National Institute for Health and Care Excellence. , 2015, European heart journal.
[8] S. Davies,et al. Our children deserve better: prevention pays , 2013, The Lancet.
[9] J. Richardson,et al. Predicting time trade-off health state valuations of adolescents in four Pacific countries using the Assessment of Quality-of-Life (AQoL-6D) instrument. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] Wolfgang Greiner,et al. Valuation of Child Health-Related Quality of Life in the United States. , 2016, Health economics.
[11] John Brazier,et al. Development of the multi-attribute Adolescent Health Utility Measure (AHUM) , 2012, Health and Quality of Life Outcomes.
[12] Mark Oppe,et al. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] P. Hinds,et al. PROMIS® pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions , 2015, Quality of Life Research.
[14] David Parkin,et al. Is there a case for using visual analogue scale valuations in cost-utility analysis? , 2006, Health economics.
[15] L. Prosser,et al. Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness , 2019, PharmacoEconomics.
[16] J. Brazier,et al. Using a discrete choice experiment to estimate health state utility values. , 2012, Journal of health economics.
[17] Katherine Stevens,et al. Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation , 2011, Applied health economics and health policy.
[18] J. Brazier,et al. Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study , 2015, Applied Health Economics and Health Policy.
[19] Andrew Briggs,et al. Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] M Sculpher,et al. EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation. , 2012, Health technology assessment.
[21] Julie Ratcliffe,et al. A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations , 2015, PharmacoEconomics.
[22] J. Brazier,et al. Valuing child health utility 9D health states with a young adolescent sample , 2011, Applied health economics and health policy.
[23] Paul Kind,et al. Can adult weights be used to value child health states? Testing the influence of perspective in valuing EQ-5D-Y , 2015, Quality of Life Research.
[24] Wendy J. Ungar,et al. Challenges in Health State Valuation in Paediatric Economic Evaluation , 2011, PharmacoEconomics.
[25] Christopher McCabe,et al. Health state values for the HUI 2 descriptive system: results from a UK survey. , 2005, Health economics.
[26] W. Furlong,et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. , 1999, JAMA.
[27] Michael Herdman,et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D , 2010, Quality of Life Research.
[28] J. Brazier,et al. Using a discrete choice experiment to estimate societal health state utility values , 2010 .
[29] Koonal Shah,et al. Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead , 2020 .
[30] 喜多 明人,et al. 「逐条解説」子どもの権利条約 = Convention on the rights of the child , 2009 .
[31] J. Varni,et al. The PedsQL: measurement model for the pediatric quality of life inventory. , 1999, Medical care.
[32] N. Hays,et al. Feasibility and Psychometric Properties of the Infant Toddler Quality of Life (ITQOL) Questionnaire in a Community-Based Sample of Healthy Infants in China , 2018, Maternal and Child Health Journal.
[33] A Simon Pickard,et al. Proxy Evaluation of Health-Related Quality of Life: A Conceptual Framework for Understanding Multiple Proxy Perspectives , 2005, Medical care.
[34] Victoria A. Miller,et al. An Emerging Field of Research , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.
[35] M. Boyle,et al. Multiattribute and Single‐Attribute Utility Functions for the Health Utilities Index Mark 3 System , 2002, Medical care.
[36] J. Brazier,et al. A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.
[37] J. Richardson,et al. Predicting time trade-off health state valuations of adolescents in four Pacific countries using the AQoL-6D instrument , 2009 .
[38] P. Veugelers,et al. Assessment of children’s own health status using visual analogue scale and descriptive system of the EQ-5D-Y: linkage between two systems , 2014, Quality of Life Research.
[39] M. Eckman,et al. Health values of adolescents with cystic fibrosis. , 2003, The Journal of pediatrics.
[40] Katherine Stevens,et al. Valuation of the Child Health Utility 9D Index , 2012, PharmacoEconomics.
[41] Christine C Bennett. A healthier future for all Australians: an overview of the final report of the National Health and Hospitals Reform Commission , 2009, The Medical journal of Australia.
[42] D. Feeny,et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. , 1996, Medical care.
[43] Dean A. Regier,et al. Evaluating health-related quality-of-life studies in paediatric populations , 2012, PharmacoEconomics.
[44] M. Essink‐bot,et al. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample , 2006, Quality of Life Research.
[45] Sarah A. Edwards,et al. Characteristics and quality of pediatric cost-utility analyses , 2012, Quality of Life Research.
[46] I. Kaitila,et al. Quality of life in pre-adolescence: A 17-dimensional health-related measure (17D) , 1996, Quality of Life Research.
[47] M. Barkham,et al. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). , 2012, Health technology assessment.
[48] John Brazier,et al. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[49] N. Devlin,et al. DO ADULT AND ADOLESCENT PREFERENCES DIFFER? , 2019 .
[50] N. Devlin,et al. EQ-5 D and the EuroQol Group : Past , Present and Future , 2017 .
[51] Katherine Stevens,et al. Developing a descriptive system for a new preference-based measure of health-related quality of life for children , 2009, Quality of Life Research.
[52] W. Brouwer. The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra , 2018, PharmacoEconomics.
[53] M. Bell,et al. Development of the multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM). , 2005, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[54] Juan Manuel Ramos-Goñi,et al. Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? , 2021, Medical decision making : an international journal of the Society for Medical Decision Making.
[55] K. Eames,et al. Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature , 2015, PloS one.
[56] S. Petrou. Methodological issues raised by preference-based approaches to measuring the health status of children. , 2003, Health economics.
[57] W. Brouwer,et al. Patient and general public preferences for health states: A call to reconsider current guidelines. , 2016, Social science & medicine.
[58] Verity Watson,et al. Is Best–Worst Scaling Suitable for Health State Valuation? A Comparison with Discrete Choice Experiments , 2017, Health economics.
[59] R. Keren,et al. Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children , 2012, PharmacoEconomics.
[60] K. Stevens,et al. Working With Children to Develop Dimensions for a Preference-Based, Generic, Pediatric, Health-Related Quality-of-Life Measure , 2010, Qualitative health research.
[61] L. Prosser,et al. Family Spillover Effects in Pediatric Cost-Utility Analyses , 2018, Applied Health Economics and Health Policy.
[62] Anne W. Riley,et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[63] Julie Ratcliffe,et al. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[64] G. Bonsel,et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study , 2010, Quality of Life Research.
[65] Richard Norman,et al. The Impact of Different DCE-Based Approaches When Anchoring Utility Scores , 2016, PharmacoEconomics.
[66] J. Brazier,et al. Experience-based utility and own health state valuation for a health state classification system: why and how to do it , 2017, The European Journal of Health Economics.
[67] N. Payakachat,et al. Progress in measuring family spillover effects for economic evaluations , 2015, Expert review of pharmacoeconomics & outcomes research.
[68] M. T. King,et al. Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format , 2016, Quality of Life Research.
[69] N. Devlin,et al. EQ-5D and the EuroQol Group: Past, Present and Future , 2017, Applied Health Economics and Health Policy.
[70] Brendan Mulhern,et al. Estimating a Dutch Value Set for the Pediatric Preference-Based CHU9D Using a Discrete Choice Experiment with Duration. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[71] H. McTaggart-Cowan. Elicitation of informed general population health state utility values: a review of the literature. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[72] Stuart Peacock,et al. Measurement of the Quality of Life for Economic Evaluation and the Assessment of Quality of Life (Aqol) Mark 2 Instrument , 2004 .
[73] John Brazier,et al. Developing Adolescent-Specific Health State Values for Economic Evaluation , 2012, PharmacoEconomics.
[74] T. Trikalinos,et al. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. , 2016, JAMA.
[75] ChiMat,et al. Annual Report of the Chief Medical Officer 2012. Our Children Deserve Better: Prevention Pays , 2008 .
[76] J. Ratcliffe,et al. Scoring the Child Health Utility 9D instrument: estimation of a Chinese child and adolescent-specific tariff , 2018, Quality of Life Research.
[77] M. Herdman,et al. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[78] John Brazier,et al. Nothing About Us Without Us? A Comparison of Adolescent and Adult Health-State Values for the Child Health Utility-9D Using Profile Case Best-Worst Scaling. , 2016, Health economics.